1st Quarter - Report

VIATRIS INC. for VIATRIS INC

Firm
Client
Income
—
Expenses
$590,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Part D Formulary Design and Generic Drug Tiering S. 1302 - Increasing Transparency in Generic Drug Applications Act H.R. 1843 - Increasing Transparency in Generic Drug Applications Act S. 775 - Increasing Transparency in Generic Drug Applications Act HR1503/S. 2916, Prescription Information Modernization Act Medicaid Generics Penalty Implementation of the Inflation Reduction Act S. 2129 Ensuring Access to Lower-Cost Medicines for Seniors Act H.R. 5461 Ensuring Access to Lower-Cost Medicies for Seniors Act Drug Shortages S. 891, the Bipartisan Health Care Act

LobbyistCovered position, as disclosed
WILL DENT —
KATHARINE HAYES —
DAVID MARIN —
PETER WALLACE —
ANNE WILSON —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 1843 (119th), S. 1302 (119th), S. 2916 (119th), S. 891 (119th), H.R. 5461 (119th), S. 2129 (119th), S. 775 (119th), H.R. 1503 (119th)

Copyright/Patent/Trademark CPT

IP Issues related to generic medicines Patent Settlements S 2220, The PREVAIL Act

LobbyistCovered position, as disclosed
WILL DENT —
KATHARINE HAYES —
DAVID MARIN —
PETER WALLACE —
ANNE WILSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

Trade issues related to generic medicines Pharmaceutical supply chain

LobbyistCovered position, as disclosed
WILL DENT —
KATHARINE HAYES —
DAVID MARIN —
PETER WALLACE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Financial Institutions/Investments/Securities FIN

Policy related to corporate governance

LobbyistCovered position, as disclosed
DAVID MARIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Defense DEF

S4638 2025 National Defense Authorization Act

LobbyistCovered position, as disclosed
WILL DENT —
PETER WALLACE —

Contacted: SENATE

Budget/Appropriations BUD

HR 9747 Countinuing Appropriations and Extensions Act of 2025 (Title II, all provisions relating to Health Extenders)

LobbyistCovered position, as disclosed
WILL DENT —
KATHARINE HAYES —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 9747 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.